Development of Diagnostic Imaging of Pancreatic Cancer using New PET Probe [11C] MePro

Yamazaki Kana0 个研究点目标入组 10 人开始时间: 2021年12月7日最近更新: 2024年1月22日

适应症

试验速览

暂无简介。

•1. Healthy male subjects aged 20 or older and under 65 at the time of informed consent
•2. Subjects who provide written informed consent
•3. Subjects with BMI of less than 25

•1. Subjects who have severe or progressive complications
•2. Subjects who have obvious abnormalities in physical and laboratory examinations after obtaining the informed consent
•3. Subjects who have past history of severe drug hypersensitivity
•4. Subjects with drug or alcohol addiction
•5. Subjects who smoke
•6. Subjects who have received medication or used vitamins, herbal medicines or supplements within14 days prior to their visit
•7. Subjects who are claustrophobic
•8. Subjects who have undergone an examination with radiation exposure for the purpose of medical treatment (X-ray, CT, PET, DEXA, etc.) within the past 12 months, or for the purpose of research within the past 6 months. Chest X-rays conducted as part of the annual medical check are excluded.
•9. Subjects who are considered to be inappropriate to participate in this study.

发起方

Yamazaki Kana